Summary by Moomoo AI
Conge Pharmaceuticals held its Annual General Meeting on 9 May 2024, and all proposed resolutions were formally approved at the meeting. The Company repurchased approximately 0.5082% of the issued shares between April 2 and 24, 2024 and will be written off. At the General Meeting, a total of 2,439,528,512 shares were granted voting rights and no shareholders abstained under the Listing Rules. IMPORTANT RESOLUTIONS PASSED AT THE MEETING INCLUDE APPROVAL OF FINAL DIVIDENDS, RE-ELECTION OF DIRECTORS, AUTHORIZATION TO REPURCHASE COMPANY SHARES, RENEWAL OF AUDITORS AND AMENDMENTS TO THE COMPANY'S ARTICLES OF ASSOCIATION AND ARTICLES OF ASSOCIATION. All directors attended the meeting.